BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 7977549)

  • 1. Family planning decisions after prenatal detection of fetal abnormalities.
    Shulman LP; Grevengood C; Phillips OP; Gross SJ; Mace PC; Elias S
    Am J Obstet Gynecol; 1994 Nov; 171(5):1373-6. PubMed ID: 7977549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results.
    Pryde PG; Drugan A; Johnson MP; Isada NB; Evans MI
    Clin Obstet Gynecol; 1993 Sep; 36(3):496-509. PubMed ID: 8403601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged induction to delivery time in termination of pregnancy using 16, 16-dimethyl-PGE1-methyl ester (gemeprost) for fetuses with a neural tube defect or hydrocephalus.
    Nesbitt D; Giles W
    Aust N Z J Obstet Gynaecol; 1996 Aug; 36(3):300-3. PubMed ID: 8883755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of abnormality influences decision to terminate pregnancies affected with fetal neural tube defects.
    Grevengood C; Shulman LP; Dungan JS; Martens P; Phillips OP; Emerson DS; Felker RE; Simpson JL; Elias S
    Fetal Diagn Ther; 1994; 9(4):273-7. PubMed ID: 7524525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive behaviour and prenatal diagnosis following genetic termination of pregnancy in women of advanced maternal age.
    Brandenburg H; De Koning W; Jahoda MG; Stijnen T; De Ridder MA; Sachs ES; Wladimiroff JW
    Prenat Diagn; 1992 Dec; 12(12):1031-5. PubMed ID: 1287638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 1 and 6 month follow-up of prenatal diagnosis patients who lost pregnancies.
    Black RB
    Prenat Diagn; 1989 Nov; 9(11):795-804. PubMed ID: 2616537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing maternal age: the actual risks.
    Chervenak JL; Kardon NB
    Female Patient; 1991 Nov; 16(11):17-24. PubMed ID: 12317779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraceptive use projections: 1990 to 2010.
    Trussell J; Vaughan B
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1160-4. PubMed ID: 1415440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose sulprostone for pregnancy termination in cases of fetal abnormality.
    Kanhai HH; Keirse MJ
    Prenat Diagn; 1993 Feb; 13(2):117-21. PubMed ID: 8464832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antenatal diagnosis and selective abortion on frequencies of genetic disorders.
    Motulsky AG; Fraser GR
    Clin Obstet Gynaecol; 1980 Apr; 7(1):121-33. PubMed ID: 6155236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal abnormalities in fetuses with open neural tube defects: prenatal identification with ultrasound.
    Sepulveda W; Corral E; Ayala C; Be C; Gutierrez J; Vasquez P
    Ultrasound Obstet Gynecol; 2004 Apr; 23(4):352-6. PubMed ID: 15065184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the Human Genome Initiative on women's rights and reproductive decisions.
    Charo RA
    Fetal Diagn Ther; 1993 Apr; 8(Suppl. 1):148-59. PubMed ID: 11653014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The choices women make about prenatal diagnosis.
    Evans MI; Pryde PG; Evans WJ; Johnson MP
    Fetal Diagn Ther; 1993 Apr; 8(Suppl. 1):70-80. PubMed ID: 11653025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of chromosome analysis in cases of neural tube defects: a case of anencephaly associated with fetal dup(2)(p24----pter).
    Singer N; Gersen S; Warburton D
    Prenat Diagn; 1987 Oct; 7(8):567-71. PubMed ID: 3317387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of transcervical chorionic villus sampling with a completed follow-up of 1550 consecutive pregnancies.
    Jahoda MG; Pijpers L; Reuss A; Los FJ; Wladimiroff JW; Sachs ES
    Prenat Diagn; 1989 Sep; 9(9):621-8. PubMed ID: 2798348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities.
    Rhoads GG; Jackson LG; Schlesselman SE; de la Cruz FF; Desnick RJ; Golbus MS; Ledbetter DH; Lubs HA; Mahoney MJ; Pergament E
    N Engl J Med; 1989 Mar; 320(10):609-17. PubMed ID: 2645520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chorionic villus needle sampling by the transabdominal route or by placental centesis. A series of 930 cases].
    Guidicelli B; Levy A; Piquet C; Gamerre M
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(8):851-5. PubMed ID: 8132961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The centralized prenatal genetics screening program of New York City III: The first 7,000 cases.
    Benn PA; Hsu LY; Carlson A; Tannenbaum HL
    Am J Med Genet; 1985 Feb; 20(2):369-84. PubMed ID: 2579556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline No. 410: Prevention, Screening, Diagnosis, and Pregnancy Management for Fetal Neural Tube Defects.
    Douglas Wilson R; Van Mieghem T; Langlois S; Church P
    J Obstet Gynaecol Can; 2021 Jan; 43(1):124-139.e8. PubMed ID: 33212246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.